In conditions including diabetes, MASLD/MASH, CVD, cancer, and neurodegeneration, ERRα helps restore energy balance, reduce oxidative and inflammatory stress, and preserve tissue function, making it a promising therapeutic target for metabolic, inflammatory, and age-related diseases. The gene discussed is ESRRA; the disease is cancer.